Piramal Critical Care (PCC) is the third largest producer of inhaled anesthetics and a global player in hospital generics. ‘Save lives with critical care solutions’ is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers across the globe, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapy for Type I Gaucher and Niemann pick Type C disease, anticholinergic, and plasma volume expander.
Our products include Sevoflurane, Desflurane, Isoflurane, Halothane, Gablofen® (Baclofen Injection), MITIGO™(Morphine Sulfate), Dipidolor® (Piritramide), Sublimaze® (Fentanyl Citrate), Rapifen® (Alfentanil Hydrochloride), Sufenta® (Sufentanil Citrate), Hypnomidate® (Etomidate), Ampicillin and Sulbactam for Injection, USP, Cefepime for Injection, USP, Ceftriaxone for Injection, USP, Oxacillin for Injection, USP, Linezolid Injection, Ampicillin for Injection, USP, Piperacillin and Tazobactam for Injection, USP, Yargesa™ (Miglustat), Glycopyrrolate and Haemaccel.